Exelixis
EXEL
#1820
Rank
S$14.21 B
Marketcap
S$52.79
Share price
-1.23%
Change (1 day)
11.78%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company